Rituximab, MMF, and IVCY showed no significant 52-week differences in lupus nephritis outcomes in SLE. Discover more.

Adicet Bio (NASDAQ:ACET) reported positive clinical data for prula-cel, its investigational allogeneic gamma delta CAR-T cell ...

Data from an early trial showed the company’s “gamma delta” cell therapy surpassed benchmarks set by personalized CAR-T ...

Lupus nephritis R&D is shifting toward targeted B-cell, complement, and off-the-shelf cell therapies, opening partnership and licensing opportunities across novel treatment platformsDublin, Sept.

A Phase I study of the investigational CAR-T cell therapy prulacabtagene leucel (prula-cel) found that some people with SLE, ...

Rheumatologist Ellen Ginzler, MD, MPH, and nephrologist German Hernandez, MD, FASN, FACP, provide an overview of systemic lupus erythematosus and lupus nephritis. Ellen Ginzler, MD, MPH: SLE, or ...

Please provide your email address to receive an email when new articles are posted on . Twelve years is a long time by most measures, but in a field has rapidly changing as lupus nephritis research, ...

Medical experts illustrate characteristics in the presentation of lupus nephritis. Jorge Larranaga, MD: Lupus nephritis can present in several ways. Lupus may take up to 6 years to be diagnosed. About ...

Lupus nephritis is a serious complication of lupus that is caused by inflammation of the kidneys. It affects up to 60% of people with lupus and usually occurs within 5 years of diagnosis. If left ...

Please provide your email address to receive an email when new articles are posted on . HUNTINGTON BEACH, Calif. — Non-nephritis lupus and lupus nephritis may actually be part of a spectrum of ...

A multicenter study led by researchers at Sultan Qaboos University has found that patients with a rare inherited form of ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Brad Rovin, MD: ...